Back to Search Start Over

Whole slide image features predict pathologic complete response and poor clinical outcomes in triple-negative breast cancer.

Authors :
Hacking SM
Karam J
Singh K
Gamsiz Uzun ED
Brickman A
Yakirevich E
Taliano R
Wang Y
Source :
Pathology, research and practice [Pathol Res Pract] 2023 Jun; Vol. 246, pp. 154476. Date of Electronic Publication: 2023 Apr 20.
Publication Year :
2023

Abstract

Introduction: Breast cancers are complex ecosystem like networks of malignant cells and their associated microenvironment. Applications for machine intelligence and the tumoral microenvironment are expanding frontiers in pathology. Previously, computational approaches have been developed to quantify and spatially analyze immune cells, proportionate stroma, and detect tumor budding. Little work has been done to analyze different types of tumor-associated stromata both quantitatively and computationally in relation to clinical endpoints.<br />Methods: We aimed to quantify stromal features from whole slide images (WSI) including stromata (myxoid, collagenous, immune) and tumoral components and combined them with traditional clinical and pathologic parameters in 120 triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NAC) to predict pathologic complete response (pCR) and poor clinical outcomes.<br />Results: High collagenous stroma on WSI was best associated with lower rates of pCR, while combined high proportionated stroma (myxoid, collagenous, and immune) most optimally predicted worse clinical survival outcomes. When combining clinical, pathologic, and WSI features, Receiver Operator Characteristics (ROC) curves for LASSO features was up to 0.67 for pCR and 0.77 for poor outcomes.<br />Conclusion: The techniques demonstrated in the present study can be performed with appropriate quality assurance. Future trials are needed to demonstrate whether coupling applications for machine intelligence, inclusive of the tumor mesenchyme, can improve outcomes prediction for patients with breast cancer.<br />Competing Interests: Declaration of Competing Interest Author SH is the founder and has ownership equity in Odyssey HealthCare Solutions Inc. The remaining authors have no other possible conflicts of interest to disclose.<br /> (Copyright © 2023 Elsevier GmbH. All rights reserved.)

Details

Language :
English
ISSN :
1618-0631
Volume :
246
Database :
MEDLINE
Journal :
Pathology, research and practice
Publication Type :
Academic Journal
Accession number :
37146413
Full Text :
https://doi.org/10.1016/j.prp.2023.154476